28/08/2012
Tuberculosis DNA, RT-PCR:
It is a test for the detection of M. tuberculosis complex in biological materials. The application of this method allows overcoming the difficulties in the diagnosis of this disease.
Toxoplasma gondii DNA, RT-PCR:
The test is based on detection of T gondii in clinical samples. It is primarily used to assist in the diagnosis of toxoplasmosis in seropositive, immunocompromised individuals, since
detection of parasitic DNA is strongly suggestive of active infection.
Hepatitis B Virus DNA Quantitative, RT-PCR:
This technique is widely used in pre-treatment evaluation and clinical staging of the disease. The quantitative HBV-DNA assays is used for assessing infectivity, for monitoring antiviral therapy and for detecting the emergence of drug resistance.
Chlamydia trachomatis DNA Quantitative, RT-PCR:
Chlamydia trachomatis is the most common sexually transmitted bacterial agent. This technique may be applied to urine samples, and this is associated with increased acceptance of C. trachomatis screening programmes among asymptomatic persons. Untreated C. trachomatis infection has been linked to serious long-term sequelae, such as ectopic pregnancy and tubal infertility
STD DNA, RT-PCR:
It is a multiplex Real Time PCR test for the qualitative detection of Neisseria gonorrhoeae, Chlamydia trachomatis,Mycoplasma genitalium and Trichomonas vaginalis in the clinical specimens. The assay is highly sensitive and specific, which offers the opportunity to use noninvasive sampling techniques to screen for infections in asymptomatic individuals who would not ordinarily seek clinical care.
Brucellosis DNA, RT-PCR:
The serological diagnosis of brucellosis lacks adequate specificity in areas where the disease is endemic and its results in some slowly evolving focal forms are difficult to interpret. PCR assays in clinical samples have proved to be more rapid and highly sensitive than conventional microbiological methods.
Human Papillomavirus (HPV) detection and Genotyping, PCR:
Ge***al infection with HPV is one of the most common STD of viral etiology worldwide. Cervical cancer is the second most common cancer in women worldwide. Several methods have been used to diagnose clinical or subclinical infection with HPVs including clinical observation, cytological screening by Pap smear, electron microscopy, immunocytochemistry, but these methods have insufficient sensitivity and low predictable value. Now a day, the most perspective way of HPV diagnosis is a direct detection of DNA of HPV of high carcinogenic risk by the PCR.
